{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:07:17Z","timestamp":1790370437047,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T00:00:00Z","timestamp":1384732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081165","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T03:29:04Z","timestamp":1384831744000},"page":"e81165","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Thrombolytic Effects of the Snake Venom Disintegrin Saxatilin Determined by Novel Assessment Methods: A FeCl3-Induced Thrombosis Model in Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Il","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Suk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hee","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hoe","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke","volume":"359","author":"W Hacke","year":"2008","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"KR Lees","year":"2010","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis","volume":"38","author":"JH Rha","year":"2007","journal-title":"Stroke"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.STR.0000251788.03914.00","article-title":"Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients","volume":"38","author":"KY Lee","year":"2007","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nm0298-228","article-title":"Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice","volume":"4","author":"YF Wang","year":"1998","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1161\/STROKEAHA.109.560201","article-title":"Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke","volume":"40","author":"VN Thijs","year":"2009","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2796.2009.02205.x","article-title":"The molecular basis of thrombolysis and its clinical application in stroke","volume":"267","author":"V Murray","year":"2010","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(08)70267-9","article-title":"Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study","volume":"8","author":"W Hacke","year":"2009","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1161\/STROKEAHA.110.595157","article-title":"Thrombolysis with plasmin: implications for stroke treatment","volume":"41","author":"VJ Marder","year":"2010","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1747-4949.2012.00783.x","article-title":"Plasminogen activation and thrombolysis for ischemic stroke","volume":"7","author":"RL Medcalf","year":"2012","journal-title":"Int J Stroke"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00005344-200304000-00011","article-title":"Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates","volume":"41","author":"M Moser","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.56.11.1585","article-title":"Rescue treatment with abciximab in acute ischemic stroke","volume":"56","author":"KY Lee","year":"2001","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V71.4.831.831","article-title":"The platelet membrane glycoprotein IIb-IIIa complex","volume":"71","author":"DR Phillips","year":"1988","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.STR.0000165918.80812.1e","article-title":"Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA\/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study","volume":"36","author":"B Eckert","year":"2005","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1212\/01.WNL.0000129480.17345.4A","article-title":"The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions","volume":"62","author":"RJ Seitz","year":"2004","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1161\/01.STR.0000179043.73314.4f","article-title":"Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb\/IIIa antagonists and angioplasty after failure of thrombolysis","volume":"36","author":"A Abou-Chebl","year":"2005","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.STR.0000080535.61188.A6","article-title":"Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations","volume":"34","author":"RJ Seitz","year":"2003","journal-title":"Stroke"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/01.WNL.0000063323.23493.98","article-title":"Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study","volume":"60","author":"JH Heo","year":"2003","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2199-8-88","article-title":"Characterization of a novel bifunctional mutant of staphylokinase with platelet-targeted thrombolysis and antiplatelet aggregation activities","volume":"8","author":"H Chen","year":"2007","journal-title":"BMC Mol Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0006-291X(02)00258-9","article-title":"Structural and functional significance of disulfide bonds in saxatilin, a 7.7 kDa disintegrin","volume":"293","author":"SY Hong","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0049-3848(01)00416-9","article-title":"Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration","volume":"105","author":"SY Hong","year":"2002","journal-title":"Thromb Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000098519","article-title":"Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion","volume":"44","author":"YJ Jang","year":"2007","journal-title":"J Vasc Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-3848(90)90106-M","article-title":"Rat model of arterial thrombosis induced by ferric chloride","volume":"60","author":"KD Kurz","year":"1990","journal-title":"Thromb Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.103.4.576","article-title":"Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice","volume":"103","author":"S Konstantinides","year":"2001","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jnr.21877","article-title":"Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia","volume":"87","author":"I Kwon","year":"2009","journal-title":"J Neurosci Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.toxicon.2007.10.019","article-title":"Acute and repeated dose toxicity studies of recombinant saxatilin, a disintegrin from the Korean snake (Gloydius saxatilis)","volume":"51","author":"YD Sohn","year":"2008","journal-title":"Toxicon"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00004647-199906000-00005","article-title":"Matrix metalloproteinases increase very early during experimental focal cerebral ischemia","volume":"19","author":"JH Heo","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-1759(91)90280-S","article-title":"Quantitative evaluation of indirect ELISA. Effect of calmodulin antagonists on antibody binding to calmodulin","volume":"143","author":"K Liliom","year":"1991","journal-title":"J Immunol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-1759(02)00295-8","article-title":"A simple method for the determination of dissociation constants by displacement ELISA","volume":"270","author":"F Orosz","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2174\/138161206777947713","article-title":"Integrins in drug targeting-RGD templates in toxins","volume":"12","author":"X Lu","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2003-05-1391","article-title":"Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo","volume":"102","author":"S Gr\u00fcner","year":"2003","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"MH Kroll","year":"1996","journal-title":"Blood"},{"key":"ref33","first-page":"257","article-title":"Platelets in hemostasis and thrombosis: role of integrins and their ligands","volume":"28","author":"H Ni","year":"2003","journal-title":"Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"32251","DOI":"10.1074\/jbc.M300410200","article-title":"Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen","volume":"278","author":"NP Podolnikova","year":"2003","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.RES.83.3.241","article-title":"Role of beta1 and beta3 integrins in human smooth muscle cell adhesion to and contraction of fibrin clots in vitro","volume":"83","author":"KO Yee","year":"1998","journal-title":"Circ Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/ki.1997.199","article-title":"Emerging paradigms of integrin ligand binding and activation","volume":"51","author":"T Sugimori","year":"1997","journal-title":"Kidney Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.200109079","article-title":"Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling","volume":"157","author":"BP Eliceiri","year":"2002","journal-title":"J Cell Biol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1538-7836.2011.04218.x","article-title":"Mechanisms underlying FeCl3-induced arterial thrombosis","volume":"9","author":"A Eckly","year":"2011","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2004.07.009","article-title":"An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research","volume":"115","author":"X Wang","year":"2005","journal-title":"Thromb Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0038-1653411","article-title":"Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro","volume":"46","author":"C Korninger","year":"1981","journal-title":"Thromb Haemost"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-7091-6391-7_11","article-title":"The clot thickens--thrombolysis and combination therapies","volume":"73","author":"M Chopp","year":"1999","journal-title":"Acta Neurochir Suppl"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1161\/01.STR.0000038096.60932.F4","article-title":"Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator","volume":"33","author":"F Niessen","year":"2002","journal-title":"Stroke"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T11:54:14Z","timestamp":1596887654000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081165"}},"subtitle":[],"editor":[{"given":"Stefan","family":"Liebner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081165","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]}}}